BBSRC Portfolio Analyser
Award details
Lactic acid bacteria as GI tract delivery vehicles
Reference
BBS/E/F/00041772
Principal Investigator / Supervisor
Dr Jerry Wells
Co-Investigators /
Co-Supervisors
Professor Michael Gasson
Institution
Quadram Institute Bioscience
Department
Quadram Institute Bioscience Department
Funding type
Research
Value (£)
131,688
Status
Completed
Type
Institute Project
Start date
01/03/2004
End date
31/03/2005
Duration
13 months
Abstract
In recent years we have seen compelling evidence that components of the normal gut microflora and probiotic strains of lactic acid bacteria play an important role in the health of the host and exert potent effects on immune function in the gut. For example Lactobacilli, which are major components of the commensal microflora, are used as probiotics and have been shown to alleviate symptoms of allergic disease and reduce the development of type I allergy through their immunoregulatory properties. This research team has a particular interest in understanding the interplay between host immune function and the lactic acid bacteria. We will investigate in the mechanisms behind the health promoting properties of probiotics and explore their use as oral delivery vehicles for therapeutic proteins and vaccines
Summary
unavailable
Committee
Closed Committee - Agri-food (AF)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search